← SynDRA
NEDISERTIB
SynDRA canonical compound SYN0039721 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | PRKDC |
|---|
| Mechanism of action | DNA dependent protein kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- DNA dependent protein kinase inhibitor
- PRKDC INHIBITOR
Drug classes
- Protein Kinase Inhibitors
Cross-references
Synonyms
- PEPOSERTIB
- M3814
- MSC2490484A
- M-3814
- MSC-2490484A
- MOWXJLUYGFNTAL-DEOSSOPVSA-N
- M-3814(nedisertib)
- nedisertib (proposed INN)
- UNII-GN429E725A
- GTPL9766
- SCHEMBL16235559
- GN429E725A
- EX-A1679
- example 136 [WO2014183850]
- HY-101570
- CS-0021723
- (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol
- Peposertib
- M 3814
- MSC 2490484A
- peposertibum
- RefChem:171540
- 1IX
- Nedisertib [INN]
- Cefdinir Impurity25
- PEPOSERTIB [INN]
- nedisertib (deleted INN)
- PEPOSERTIB [WHO-DD]
- orb2279863
- SCHEMBL29417846
- SCHEMBL29538639
- SCHEMBL30482760
- BDBM315715
- NSC802822
- NSC816960
- US10172859, Example 136
- EBC-515469
- MSC 2490484A [WHO-DD]
Look up NEDISERTIB in the interactive SynDRA portal →